Publication | Closed Access
FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity
74
Citations
19
References
2013
Year
InflammationChronic Inflammatory DiseasesMucosal ImmunologyMedicinePathogenesisImmunologyInflammation BiologyPathologyChronic InflammationAutoimmunityAdcc ActivityImmune-mediated Inflammatory DiseasesImmune FunctionBiological ResponseFcgr3a-158 PolymorphismInflammatory Disease
| Year | Citations | |
|---|---|---|
Page 1
Page 1